Document is current
Any future updates will be listed below
-
Authors
Pipicella, Joseph Louis https://orcid.org/0000-0002-1796-918X
Vernon-Roberts, Angharad
Dutt, Shoma
Giles, Edward
Day, Andrew S.
Connor, Susan Jane
Andrews, Jane Mary
-
Funding
Funding for this research was provided by:
Leona M. and Harry B. Helmsley Charitable Trust (#2002-04267)
University of New South Wales
- License Information
-
More Information
Article History
Received: 3 July 2023
Accepted: 5 October 2023
First Online: 28 October 2023
Declarations
:
: Joseph Louis Pipicella—Crohn’s Colitis Cure Company Secretary. Edward Giles—Advisory Boards: AbbVie, Janssen; Speaker Fees: Takeda, Janssen, Nutricia, Aspen Nutritionals, AbbVie, Evolution Health, H&H Group. Andrew S. Day—Honoraria: AbbVie, Janssen and Nestle; Research Support: Cure Kids; Cure Kids Chair of Paediatric Research. Susan Jane Connor—Advisory Board participation, speaker fees, educational support and/or research support from: AbbVie, Amgen, BMS, Celltrion, Chiesi, Dr Falk, Eli-Lilly, Ferring, Fresenius Kabi, Gilead, GSK, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Takeda, Vifor, Agency for Clinical Innovation, Gastroenterological Society of Australia, Medical Research Future Fund, South Western Sydney Local Health District, Sydney Partnership for Health, Research and Enterprise (SPHERE) and The Leona M and Harry B Helmsley Charitable Trust; Member of the Australia New Zealand IBD Consortium; Crohn’s Colitis Cure Board Member; South Western Sydney Local Health District employee. Jane Mary Andrews—Speaker’s fees, research support, Ad Boards, industry consultation within last 3 years: AbbVie, Allergan, Anatara, Atmo Capsule, Bayer, BMS 2020, Celgene, Celltrion, Falk, Ferring Fresenius Kabi, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020–2022, The Helmsley Trust 2020–2023; Crohn’s Colitis Cure Board Chair; The Gastroenterological Society of Australia Board Member; Central Adelaide Local Health Network employee.
: This study was ethically approved by the South Western Sydney Local Health District Human Research and Ethics Committee (HREC) (2021/ETH11378) and the University of Otago Ethics Committee (Health), New Zealand (H21/116).
: People with IBD and Parents: A participant information sheet was displayed online prior to online consent being obtained. Clinicians: Participation was voluntary; thus, no formal consent was required.
